IP Library Granted Patent US 7,618,619
Granted Patent B2
US 7,618,619 · App. 10/236,661 · Granted Nov 17, 2009

Colored visco-elastic composition

Assignee: Medical Technology Transfer Holding B.V.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,618,619
App. No.
10/236,661
Granted
Nov 17, 2009
Kind
B2
Abstract

The invention relates to a visco-elastic composition for use in ocular surgery and to a method of using said composition. Specifically, the present visco-elastic composition comprises a visco-elastic substance and at least one vital dye. The invention enables a visual distinction of the visco-elastic composition from the surrounding aqueous or intraocular structures during ocular surgery, so that the amount present within the eye, the location and the effects of the visco-elastic material can be better monitored.

Claims (9)

1. A method of performing intraocular surgery, refractive surgery, cataract surgery, coreal surgery, glaucoma surgery, posterior segment surgery, or retinal detachment surgery comprising the application of a composition to a human eye or a part thereof wherein the composition comprises at least one visco-elastic substance and at least one vital dye, which dye substantially does not diffuse out of the visco-elastic composition, and wherein the dye has a molecular weight below 2,000 D and is represented by formula (I)

wherein R 1 and R 2 are the same or different aryl groups, and wherein R 3 and R 4 are independently chosen from hydrogen, methyl, ethyl, methoxy, amino, hydroxyl, and sulfonate.

2. The method of claim 1 , wherein the visco-elastic substance is hyaluronic acid or hydroxypropyl methylcellulose.

3. The method of claim 1 , wherein R 1 and R 2 are the same and formed by naphthyl groups substituted with one or more of sulfonate groups, amino groups and hydroxyl groups.

4. A method of performing intraocular surgery, refractive surgery, cataract surgery, coreal surgery, glaucoma surgery, posterior segment surgery, or retinal detachment surgery comprising the application of a composition to a human eye or a part thereof wherein the composition comprises at least one visco-elastic substance and trypan blue, wherein the trypan blue substantially does not diffuse out of the visco-elastic composition, and wherein the trypan blue is capable of staining tissue substantially without diffusing through said tissue.

5. The method of claim 1 , wherein the composition has the form of a physiologically compatible solution or colloidal gel.

6. The method of claim 1 , wherein at least one vital dye is present in a concentration between 0.0005 and 0.01 wt. %, based on the weight of the composition.

7. The method of claim 1 , wherein at least one vital dye is present in a concentration between 0.01 and 1 wt. %, based on the weight of the composition.

8. The method of claim 1 , wherein the composition further comprises between 0.8 and 1.0 wt. %, based on the weight of the solution, of a salt.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 28, 2018
From: FENELON HOLLAND HOLDING B.V.
To: D.O.R.C. DUTCH OPHTHALMIC RESEARCH CENTER (INTERNATIONAL) B.V.
Reel/Frame 045371/0704 →
CHANGE OF NAME Recorded Mar 22, 2018
From: MEDICAL TECHNOLOGY TRANSFER HOLDING B.V.
To: FENELON HOLLAND HOLDING B.V.
Reel/Frame 045311/0044 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2003
From: MELLES, GERRIT REINOLD JACOB
To: MEDICAL TECHNOLOGY TRANSFER HOLDING B.V.
Reel/Frame 014116/0449 →
Continuity (2)
Continuation PCTNL010018800 · Mar 7, 2001
Related Publication 20030088233A1 · May 8, 2003